Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Sodium Glucose Transporter Inhibitor (SGLT2i) in Adult Patients With Congenital Heart Disease

NCT06260059 is registered in ClinicalTrials.gov with Anita Saraf as lead sponsor.

NCT NCT06260059
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06260059 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Sodium Glucose Transporter Inhibitor (SGLT2i) in Adult Patients With Congenital Heart Disease
Lead sponsor
Anita Saraf
Phase
Phase 4
Overall status
Active, not recruiting
Start date
September 17, 2024
Completion date
June 1, 2027
Enrollment
40 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

adult congenital heart disease, heart failure